Fidelity Investments
Fidelity Investments, founded in 1946 and headquartered in Boston, Massachusetts, is a privately owned investment management firm that offers a wide range of financial services. These services include individual retirement accounts (IRAs), 401(k) rollovers, annuities, discount brokerage, retirement planning, estate planning, wealth management, and life insurance. The firm caters to individual investors, businesses, financial advisors, and institutions, managing equity, fixed income, and balanced mutual funds. Fidelity invests in global public equity and fixed income markets, employing in-house research to inform its investment decisions. The firm serves over 32 million individuals, assists more than 22,000 businesses in managing employee benefits, and provides support to over 13,000 financial institutions with innovative solutions. Fidelity operates through numerous regional offices and Investor Centers across the United States.
Wasabi Technologies, Inc. is a cloud storage provider that offers a fast and cost-effective platform for hybrid and multi-cloud media workflows. The company specializes in hot storage solutions compatible with Amazon S3, delivering average time-to-first-byte speeds of less than 15 milliseconds and ensuring data integrity with active checking. Wasabi's services support a variety of applications, including archiving, backup and recovery, content delivery, and data analytics, catering to sectors such as media and entertainment, education, healthcare, and law enforcement. The company provides a free trial capped at 1 TB of storage and offers flexible pricing options, ensuring that organizations can access secure and reliable data storage without complex pricing structures or unpredictable fees. Founded in 2016 and headquartered in Boston, Massachusetts, Wasabi was previously known as BlueArchive, Inc. before rebranding in 2017.
Provider of cancer therapy services intended to improve both the safety and efficacy of cytokine immunotherapies for cancer patients. The company's services offer systemic dosing of these immune stimulants that have historically been limited by broad immune activation and toxicity, develops cancer therapies based on tumor-localized immune potentiating agents that boost anti-tumor immune responses, enabling patients to find an instant treatment for cancer without any surgery.
Wasabi Technologies, Inc. is a cloud storage provider that offers a fast and cost-effective platform for hybrid and multi-cloud media workflows. The company specializes in hot storage solutions compatible with Amazon S3, delivering average time-to-first-byte speeds of less than 15 milliseconds and ensuring data integrity with active checking. Wasabi's services support a variety of applications, including archiving, backup and recovery, content delivery, and data analytics, catering to sectors such as media and entertainment, education, healthcare, and law enforcement. The company provides a free trial capped at 1 TB of storage and offers flexible pricing options, ensuring that organizations can access secure and reliable data storage without complex pricing structures or unpredictable fees. Founded in 2016 and headquartered in Boston, Massachusetts, Wasabi was previously known as BlueArchive, Inc. before rebranding in 2017.
Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company’s VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Karuna Pharmaceuticals, Inc. engages in development of drugs for the treatment of schizophrenia. The company was incorporated in 2009 and is based in Boston, Massachusetts.
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.
Handy Technologies, Inc., doing business as Handy, operates an online platform for connecting individuals looking for household services with independent service professionals. It offers repair and maintenance services, which includes air conditioner services, furniture assembly services, plumbing services, electrical services, and home cleaning services. Handy Technologies, Inc. was formerly known as Handybook, Inc. and changed its name to Handy Technologies, Inc. in September 2014. The company was founded in 2012 and is based in New York, New York having additional offices in Boston, Chicago, London, Los Angeles, San Francisco, Toronto, and Vancouver. Handy Technologies, Inc. operates as a subsidiary of ANGI Homeservices Inc.
Wave Life Sciences
Series B in 2015
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.